DNA-PCR and RT-PCR for the 18-kDa gene of Mycobacterium leprae to assess the efficacy of multi-drug therapy for leprosy.

DNA-PCR and reverse transcription (RT)-PCR for the 18-kDa protein of Mycobacterium leprae were used to examine the efficacy of multi-drug therapy (MDT) in leprosy. MDT was administered for 0-24 months. Fourteen (63.6%) of 22 patients showed positive PCR results after treatment for 12 months and the positive results decreased to 30% after 24 months of MDT. These results did not correlate with the bacterial index (BI) or the IgM antibody titre for the phenolic glycolipid (PGL)-1. One-dimensional densitometric analysis of agarose gels from PCR from the longitudinal study showed a gradual reduction of the 360-bp band after 12-24 months of MDT. RT-PCR for mRNA of the 18-kDa protein successfully tracked bacterial RNA changes in the biopsies and confirmed a decrease in the RNA of M. leprae in patients after MDT for 12 months. Thus, DNA- and RT-PCR for the 18-kDa protein of M. leprae are effective in assessing the efficacy of MDT for leprosy.

[1]  H. Donoghue,et al.  PCR primers that can detect low levels of Mycobacterium leprae DNA. , 2001, Journal of medical microbiology.

[2]  J. Ryon,et al.  Reverse Transcription-PCR Detection ofMycobacterium leprae in Clinical Specimens , 1998, Journal of Clinical Microbiology.

[3]  R. Paul,et al.  DNA Amplification for Detection of Leprosy and Assessment of Efficacy of Leprosy Chemotherapy , 1998 .

[4]  V. Pai,et al.  Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions. , 1997, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[5]  P. Klatser,et al.  Use of NASBA RNA amplification for detection of Mycobacterium leprae in skin biopsies from untreated and treated leprosy patients. , 1996, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[6]  K. Kampirapap,et al.  Detection of Mycobacterium leprae infection by PCR , 1995, Journal of clinical microbiology.

[7]  N. Stoker,et al.  A colorimetric PCR method for the detection of M. leprae in skin biopsies from leprosy patients. , 1994, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[8]  H. Dockrell,et al.  Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy , 1993, The Lancet.

[9]  G. P. Walsh,et al.  Evaluation of polymerase chain reaction amplification of Mycobacterium leprae-specific repetitive sequence in biopsy specimens from leprosy patients , 1993, Journal of clinical microbiology.

[10]  D. Williams,et al.  Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. , 1992, Molecular and cellular probes.

[11]  R. Cox,et al.  The 16S ribosomal RNA of Mycobacterium leprae contains a unique sequence which can be used for identification by the polymerase chain reaction. , 1991, Journal of medical microbiology.

[12]  J T Douglas,et al.  Application of a polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues , 1991, Journal of clinical microbiology.

[13]  P. Brennan,et al.  Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens. , 1991, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[14]  B. Plikaytis,et al.  Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay , 1990, Journal of clinical microbiology.

[15]  R. Booth,et al.  The use of a specific DNA probe and polymerase chain reaction for the detection of Mycobacterium leprae. , 1990, The Journal of infectious diseases.

[16]  P. Fine,et al.  Seroepidemiological studies of leprosy in northern Malawi based on an enzyme-linked immunosorbent assay using synthetic glycoconjugate antigen. , 1988, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[17]  D. Young,et al.  Detection of phenolic glycolipid I in sera from patients with lepromatous leprosy. , 1985, The Journal of infectious diseases.

[18]  D. H. McRae,et al.  A method for counting acid-fast bacteria. , 1968, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[19]  R. Rees,et al.  Changes in the morphology of Mycobacterium leprae in patients under treatment. , 1962, International journal of Leprosy.

[20]  C. Shepard.  THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICE , 1960, The Journal of experimental medicine.